Vistra reports third quarter net income of $652 million and adjusted EBITDA of $1.58 billion

Reuters
2025/11/06
<a href="https://laohu8.com/S/VST">Vistra</a> reports third quarter net income of $652 million and adjusted EBITDA of $1.58 billion

Vistra Corporation reported a third quarter 2025 GAAP net income of $652 million and Ongoing Operations Adjusted EBITDA of $1,581 million. Net income for the quarter decreased by $1,185 million compared to the third quarter of 2024, mainly due to lower unrealized mark-to-market gains on derivative positions and impacts from the Martin Lake Unit 1 outage, partially offset by nuclear production tax credit revenue and higher capacity prices. The company narrowed its 2025 Ongoing Operations Adjusted EBITDA guidance to a range of $5.7 billion to $5.9 billion and raised the midpoint and narrowed the range for Ongoing Operations Adjusted FCFbG to $3.3 billion to $3.5 billion. Vistra also initiated 2026 guidance, projecting Ongoing Operations Adjusted EBITDA between $6.8 billion and $7.6 billion and Ongoing Operations Adjusted FCFbG between $3.9 billion and $4.7 billion. During the period, approximately 2,600 MW of capacity was added to the company's portfolio across the Midwest, Northeast, and California markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vistra Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-268033), on November 06, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10